Trial Profile
A retrospective study of patients with metastatic colorectal cancer (mCRC) who were treated with LONSURF (trifluridine and tipiracil) or Stivarga (regorafenib)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Regorafenib
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2018 New trial record
- 28 Sep 2018 According to a Taiho Oncology media release, data will be presented at the 2018 ASCO Quality of Care Symposium (ASCO QCS) by Anuj Patel of Dana-Farber Cancer Institute.
- 28 Sep 2018 Results published in the Taiho Oncology Media Release